Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).

Schneider MP, Tornic J, Sýkora R, Abo Youssef N, Mordasini L, Krhut J, Chartier-Kastler E, Davies M, Gajewski J, Schurch B, Bachmann LM, Kessler TM.

Neurourol Urodyn. 2019 May 16. doi: 10.1002/nau.24039. [Epub ahead of print] Review.

PMID:
31099113
2.

Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study.

Michel F, Ciceron C, Bernuz B, Boissier R, Gaillet S, Even A, Chartier-Kastler E, Denys P, Gamé X, Ruffion A, Normand LL, Perrouin-Verbe B, Saussine C, Manunta A, Forin V, De Seze M, Grise P, Tournebise H, Schurch B, Karsenty G.

Urology. 2019 Mar 26. pii: S0090-4295(19)30265-1. doi: 10.1016/j.urology.2019.03.010. [Epub ahead of print]

PMID:
30926380
3.

[About the indications to urodynamic studies and to a prior antibioprophylaxy].

Micol LA, Rakauskas A, Schurch B.

Rev Med Suisse. 2018 Nov 28;14(629):2167-2171. Review. French.

PMID:
30484975
4.

Targeted neurotechnology restores walking in humans with spinal cord injury.

Wagner FB, Mignardot JB, Le Goff-Mignardot CG, Demesmaeker R, Komi S, Capogrosso M, Rowald A, Seáñez I, Caban M, Pirondini E, Vat M, McCracken LA, Heimgartner R, Fodor I, Watrin A, Seguin P, Paoles E, Van Den Keybus K, Eberle G, Schurch B, Pralong E, Becce F, Prior J, Buse N, Buschman R, Neufeld E, Kuster N, Carda S, von Zitzewitz J, Delattre V, Denison T, Lambert H, Minassian K, Bloch J, Courtine G.

Nature. 2018 Nov;563(7729):65-71. doi: 10.1038/s41586-018-0649-2. Epub 2018 Oct 31.

PMID:
30382197
5.

What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.

Malde S, Fry C, Schurch B, Marcelissen T, Averbeck M, Digesu A, Sahai A.

Neurourol Urodyn. 2018 Jun;37(S4):S108-S116. doi: 10.1002/nau.23552. Review.

PMID:
30133790
6.

Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.

Peyronnet B, Even A, Capon G, De Seze M, Hascoet J, Biardeau X, Baron M, Perrouin-Verbe MA, Boutin JM, Saussine C, Phé V, Lenormand L, Chartier-Kastler E, Cornu JN, Karsenty G, Manunta A, Schurch B, Denys P, Amarenco G, Game X; GENULF and the AFU Committee of NeuroUrology.

J Urol. 2018 Oct;200(4):875-880. doi: 10.1016/j.juro.2018.05.006. Epub 2018 May 8.

PMID:
29746860
7.

The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.

Rahnama'i MS, Marcelissen T, Apostolidis A, Veit-Rubin N, Schurch B, Cardozo L, Dmochowski R.

Neurourol Urodyn. 2018 Jun;37(S4):S99-S107. doi: 10.1002/nau.23493. Epub 2018 Jan 24. Review.

PMID:
29363792
9.

An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD).

Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, Dickinson T, Payne CK, Drake MJ, Haylen BT.

Neurourol Urodyn. 2018 Mar;37(3):1152-1161. doi: 10.1002/nau.23397. Epub 2017 Nov 17.

PMID:
29149505
10.

[Nocturia in aged patient: in practice].

Da Costa A, Ishida M, Akrour R, Mary-Heck G, Grilo N, Schurch B, Lang PO.

Rev Med Suisse. 2017 Nov 8;13(582):1946-1951. French.

PMID:
29120542
11.

Urodynamics in patients with spinal cord injury: A clinical review and best practice paper by a working group of The International Continence Society Urodynamics Committee.

Schurch B, Iacovelli V, Averbeck MA, Stefano C, Altaweel W, Finazzi Agrò E.

Neurourol Urodyn. 2018 Feb;37(2):581-591. doi: 10.1002/nau.23369. Epub 2017 Aug 1. Review.

PMID:
28762566
12.

Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.

Joussain C, Popoff M, Phé V, Even A, Bosset PO, Pottier S, Falcou L, Levy J, Vaugier I, Chartier Kastler E, Schurch B, Denys P.

Neurourol Urodyn. 2018 Feb;37(2):799-806. doi: 10.1002/nau.23352. Epub 2017 Jul 26.

PMID:
28745807
13.

A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injury.

Mignardot JB, Le Goff CG, van den Brand R, Capogrosso M, Fumeaux N, Vallery H, Anil S, Lanini J, Fodor I, Eberle G, Ijspeert A, Schurch B, Curt A, Carda S, Bloch J, von Zitzewitz J, Courtine G.

Sci Transl Med. 2017 Jul 19;9(399). pii: eaah3621. doi: 10.1126/scitranslmed.aah3621.

PMID:
28724575
14.

Long-term compliance and results of intravesical botulinum toxin A injections in male patients.

Rahnama'i MS, Marcelissen TAT, Brierley B, Schurch B, de Vries P.

Neurourol Urodyn. 2017 Sep;36(7):1855-1859. doi: 10.1002/nau.23196. Epub 2017 Jan 13.

PMID:
28084637
15.

Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.

Marcelissen TA, Rahnama'i MS, Snijkers A, Schurch B, De Vries P.

World J Urol. 2017 Feb;35(2):307-311. doi: 10.1007/s00345-016-1862-y. Epub 2016 Jun 7.

PMID:
27272312
16.

[Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey].

Peyronnet B, Sanson S, Amarenco G, Castel-Lacanal E, Chartier-Kastler E, Charvier K, Damphousse M, Denys P, de Seze M, Egon G, Even A, Forin V, Karsenty G, Kerdraon J, le Normand L, Loche CM, Manunta A, Mouracade P, Phe V, Previnaire JG, Ruffion A, Saussine C, Schurch B, Game X; Membres du GENULF (Groupe d’étude de neuro-urologie de langue française) et du comité de neuro-urologie de l’AFU (Association française d’urologie).

Prog Urol. 2015 Dec;25(17):1219-24. doi: 10.1016/j.purol.2015.07.006. Epub 2015 Aug 28. French.

PMID:
26318394
17.

Neuroprosthetic technologies to augment the impact of neurorehabilitation after spinal cord injury.

van den Brand R, Mignardot JB, von Zitzewitz J, Le Goff C, Fumeaux N, Wagner F, Capogrosso M, Martin Moraud E, Micera S, Schurch B, Curt A, Carda S, Bloch J, Courtine G.

Ann Phys Rehabil Med. 2015 Sep;58(4):232-237. doi: 10.1016/j.rehab.2015.04.003. Epub 2015 Jun 19. Review.

18.

Dysfunction of lower urinary tract in patients with spinal cord injury.

Schurch B, Tawadros C, Carda S.

Handb Clin Neurol. 2015;130:247-67. doi: 10.1016/B978-0-444-63247-0.00014-6. Review.

PMID:
26003248
19.

Supraspinal Control of Urine Storage and Micturition in Men--An fMRI Study.

Michels L, Blok BF, Gregorini F, Kurz M, Schurch B, Kessler TM, Kollias S, Mehnert U.

Cereb Cortex. 2015 Oct;25(10):3369-80. doi: 10.1093/cercor/bhu140. Epub 2014 Jun 26.

20.

OnabotulinumtoxinA and multiple sclerosis.

Schurch B, Carda S.

Ann Phys Rehabil Med. 2014 Jul;57(5):302-314. doi: 10.1016/j.rehab.2014.05.004. Epub 2014 Jun 5. Review.

21.

[Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].

Tawadros C, Tawadros T, Julita L, Jichlinski P, Schurch B.

Rev Med Suisse. 2013 Dec 4;9(409):2286-8. French.

PMID:
24416885
22.

Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.

Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, Schurch B, Sievert KD, Engeler DS.

Eur Urol. 2010 Dec;58(6):865-74. doi: 10.1016/j.eururo.2010.09.024. Epub 2010 Oct 1. Review.

PMID:
20934242
23.

The supraspinal neural correlate of bladder cold sensation--an fMRI study.

Mehnert U, Michels L, Zempleni MZ, Schurch B, Kollias S.

Hum Brain Mapp. 2011 Jun;32(6):835-45. doi: 10.1002/hbm.21070. Epub 2010 May 24.

PMID:
20661957
24.

The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.

Mehnert U, Birzele J, Reuter K, Schurch B.

J Urol. 2010 Sep;184(3):1011-6. doi: 10.1016/j.juro.2010.05.035.

PMID:
20643431
25.

New strategies of pelvic nerves stimulation for recovery of pelvic visceral functions and locomotion in paraplegics.

Possover M, Schurch B, Henle KP.

Neurourol Urodyn. 2010 Nov;29(8):1433-8. doi: 10.1002/nau.20897.

PMID:
20589714
26.

What treatment should we use if drugs fail for OAB; and, what really works after drugs?

Bosch JL, Kelleher C, van Kerrebroeck PE, Schurch B.

Neurourol Urodyn. 2010 Apr;29(4):658-61. doi: 10.1002/nau.20906.

PMID:
20432331
27.

The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects.

Schiffers M, Sauermann P, Schurch B, Mehnert U.

World J Urol. 2010 Oct;28(5):651-6. doi: 10.1007/s00345-010-0513-y. Epub 2010 Feb 7.

PMID:
20140437
28.

Neurologic fecal incontinence.

Wyndaele JJ, Kovindha A, Igawa Y, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, Castro D, Sakakibara R, Wein A; ICI 2009 Committee 10.

Neurourol Urodyn. 2010;29(1):207-12. doi: 10.1002/nau.20853. Review.

PMID:
20025022
29.

Neurologic urinary incontinence.

Wyndaele JJ, Kovindha A, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, Castro D, Igawa Y, Sakakibara R, Wein A; Committe 10 on Neurogenic Bladder and Bowel of the International Consultation on Incontinence 2008-2009.

Neurourol Urodyn. 2010;29(1):159-64. doi: 10.1002/nau.20852. Review.

PMID:
20025021
30.

Cortical substrate of bladder control in SCI and the effect of peripheral pudendal stimulation.

Zempleni MZ, Michels L, Mehnert U, Schurch B, Kollias S.

Neuroimage. 2010 Feb 15;49(4):2983-94. doi: 10.1016/j.neuroimage.2009.10.064. Epub 2009 Oct 28.

PMID:
19878725
31.
32.

The somatosensory representation of the human clitoris: an fMRI study.

Michels L, Mehnert U, Boy S, Schurch B, Kollias S.

Neuroimage. 2010 Jan 1;49(1):177-84. doi: 10.1016/j.neuroimage.2009.07.024. Epub 2009 Jul 23.

PMID:
19631756
33.

Outcome measures in spinal cord injury: recent assessments and recommendations for future directions.

Alexander MS, Anderson KD, Biering-Sorensen F, Blight AR, Brannon R, Bryce TN, Creasey G, Catz A, Curt A, Donovan W, Ditunno J, Ellaway P, Finnerup NB, Graves DE, Haynes BA, Heinemann AW, Jackson AB, Johnston MV, Kalpakjian CZ, Kleitman N, Krassioukov A, Krogh K, Lammertse D, Magasi S, Mulcahey MJ, Schurch B, Sherwood A, Steeves JD, Stiens S, Tulsky DS, van Hedel HJ, Whiteneck G.

Spinal Cord. 2009 Aug;47(8):582-91. doi: 10.1038/sc.2009.18. Epub 2009 Apr 21. Review.

34.

The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.

Mehnert U, Boy S, Widmer-Simitovic S, Reitz A, Schurch B.

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun;20(6):659-66. doi: 10.1007/s00192-009-0836-7. Epub 2009 Mar 7.

PMID:
19271093
35.

[Botulinum toxin in nonneurogenic bladder dysfunction].

Mehnert U, Schurch B.

Urologe A. 2009 Mar;48(3):233-44. doi: 10.1007/s00120-008-1918-8. Review. German.

PMID:
19194690
36.

A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.

Mehnert U, Boy S, Schmid M, Reitz A, von Hessling A, Hodler J, Schurch B.

World J Urol. 2009 Jun;27(3):397-403. doi: 10.1007/s00345-008-0362-0. Epub 2009 Jan 15.

PMID:
19145439
37.

Heart rate variability: an objective measure of autonomic activity and bladder sensations during urodynamics.

Mehnert U, Knapp PA, Mueller N, Reitz A, Schurch B.

Neurourol Urodyn. 2009;28(4):313-9. doi: 10.1002/nau.20641.

PMID:
19058189
38.

International standards to document remaining autonomic function after spinal cord injury.

Alexander MS, Biering-Sorensen F, Bodner D, Brackett NL, Cardenas D, Charlifue S, Creasey G, Dietz V, Ditunno J, Donovan W, Elliott SL, Estores I, Graves DE, Green B, Gousse A, Jackson AB, Kennelly M, Karlsson AK, Krassioukov A, Krogh K, Linsenmeyer T, Marino R, Mathias CJ, Perkash I, Sheel AW, Schilero G, Schurch B, Sonksen J, Stiens S, Wecht J, Wuermser LA, Wyndaele JJ.

Spinal Cord. 2009 Jan;47(1):36-43. doi: 10.1038/sc.2008.121. Epub 2008 Oct 28. Review. Erratum in: Spinal Cord. 2009 Jul;47(7):575. Shilero, G [corrected to Schilero, G].

PMID:
18957962
39.

Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, Karsenty G, Schulte-Baukloh H, Schurch B, Wyndaele JJ; European Consensus Panel.

Eur Urol. 2009 Jan;55(1):100-19. doi: 10.1016/j.eururo.2008.09.009. Epub 2008 Sep 17. Review.

PMID:
18823697
40.
41.

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Naumann M, So Y, Argoff CE, Childers MK, Dykstra DD, Gronseth GS, Jabbari B, Kaufmann HC, Schurch B, Silberstein SD, Simpson DM; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2008 May 6;70(19):1707-14. doi: 10.1212/01.wnl.0000311390.87642.d8.

PMID:
18458231
42.

Brain activation in response to bladder filling and simultaneous stimulation of the dorsal clitoral nerve--an fMRI study in healthy women.

Mehnert U, Boy S, Svensson J, Michels L, Reitz A, Candia V, Kleiser R, Kollias S, Schurch B.

Neuroimage. 2008 Jul 1;41(3):682-9. doi: 10.1016/j.neuroimage.2008.03.006. Epub 2008 Mar 18.

PMID:
18434200
43.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E.

Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.

PMID:
17988791
44.
45.

Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.

Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E.

Eur Urol. 2007 Dec;52(6):1729-35. Epub 2007 Sep 4.

PMID:
17884281
46.
47.
48.

[Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections].

Karsenty G, Corcos J, Schurch B, Ruffion A, Chartier-Kastler E.

Prog Urol. 2007 May;17(3):568-75. French.

PMID:
17622092
50.

Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL.

Eur Urol. 2007 Sep;52(3):850-8. Epub 2007 Apr 19.

PMID:
17467889

Supplemental Content

Loading ...
Support Center